2024-11-19 19:19:38
Everest Medicines Announces European Commission Grants Approval of Kinpeygo® for Adults with Primary IgA Nephropathy to our Partner Calliditas Therapeutics
Corporate/ 2023-07-24
Everest Medicines Announces European Com...

Kinpeygo® (developed under the name NEFECON) is the first and only EMA- approved treatment for IgAN

BRONCUS COMPLETED SURGERIES ON THE FIRST GROUP OF PATIENTS USING ITS InterVapor®, THE THERMAL VAPOR TREATMENT SYSTEM, AFTER APPROVED FOR MARKETING IN CHINA
Corporate/ 2023-07-24
BRONCUS COMPLETED SURGERIES ON THE FIRST...

HANGZHOU,China,July 18,2022--Broncus Medical (02216.HK) has completed surgeries on the first group of patients using its InterVapor®(inc...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release